Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN118638038B reveals novel chiral isothiourea catalysis for high-purity indole amides. Enables cost reduction and scalable supply chain for pharmaceutical intermediates manufacturing.
Patent CN112125856A reveals a safe palladium-catalyzed route to 2-trifluoromethyl quinazolinones using solid CO surrogates, offering significant cost and safety advantages for pharmaceutical manufacturing.
Patent CN116813544B reveals metal-free heating method for quinoline synthesis offering supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN112920173A details a chiral phosphoric acid catalyzed synthesis of cytotoxic chroman derivatives, offering high enantioselectivity and scalable manufacturing for anticancer drug development.
Novel nitrile hydratase method for Eluxadoline intermediate offers high yield and mild conditions, ensuring reliable supply chain and cost efficiency.
Patent CN113735778B reveals efficient Ag2O promoted route. Offers cost reduction and scalable supply for pharmaceutical intermediates manufacturing globally.
Patent CN101407459B details a novel synthesis of monohydroxy-2-acylphenylacetates. This route offers scalable production for antitumor drug leads with optimized cost efficiency.
Patent CN115772157B reveals cobalt-catalyzed synthesis enabling cost reduction and scalable supply chain reliability for high-purity pharmaceutical intermediates globally.
Patent CN114920707B reveals a novel iodine-promoted synthesis using DMF as a carbon source. This method offers significant cost reduction in API manufacturing and simplified supply chains for pharmaceutical intermediates.
Novel iodine-promoted cyclization using DMF as carbon source. Streamlines API intermediate manufacturing with high efficiency and operational simplicity.
Patent CN113880781A reveals a novel glucose-derived route for 3-trifluoromethyl-1,2,4-triazoles, offering sustainable cost reduction and scalable API intermediate manufacturing.
Novel Pd-catalyzed route for trifluoroacetyl indoline. Reduces cost and improves scalability for pharmaceutical intermediates.
Patent CN114539044B enables high-yield Anhydroicaritin production. Novel route ensures purity and supply chain stability for global pharmaceutical manufacturers.
Patent CN119060008A reveals novel palladium-catalyzed pathway for benzopyran thioesters. Offers significant supply chain stability and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN104140430B enables recycling of S-isomers via halogenation. Reduces waste and cost for pharmaceutical intermediate manufacturing supply chains.
Efficient Rh-catalyzed oxidative cyclization for fused heterocycles. Reduces steps and cost for high-purity pharmaceutical intermediates manufacturing.
Patent CN114524701B reveals a novel chiral phosphoric acid catalyzed route for N-N axis chiral pyrroles, offering high enantioselectivity and cytotoxic potential for drug discovery.
Novel CO2 fixation method for benzoxazin-2-one derivatives. Green chemistry, high yield, scalable pharmaceutical intermediate manufacturing process for global supply.
Novel photocatalytic method for cyanosulfonyl fluoride compounds offers efficient synthesis and supply chain advantages for pharmaceutical intermediates manufacturing globally.
Patent CN114920707B reveals a novel iodine-promoted cyclization using DMF as a carbon source, offering significant cost reduction in API manufacturing and simplified supply chains.